Insitro's Daphne Koller: No Magic Wands in AI Drug Discovery, Focus on Mechanisms
zakkohane · x · 2026-08-09
Insitro founder and CEO Daphne Koller published a detailed essay pushing back against the tech world's fantasy that superintelligence will easily cure all diseases.
She argues that our understanding of human biology remains highly limited, meaning powerful AI reasoning alone cannot magically discover cures from existing knowledge. The real bottleneck is finding new disease mechanisms, not just finding drugs for known mechanisms. AI-assisted, causally focused exploration is the necessary precondition for transformative breakthroughs in medicine.
More from AGI Musings
- Personal shopping agents bumped her secondhand spending from $365 to $820 in 2 months — davidyin44 · 2026-10-16
- There's no formal route to frontier AI research: 19-year-olds are advancing tech from their basements — repligate · 2026-10-16
- 'Will you end humanity?' AI's candid answer becomes a clown meme — dermflork · 2026-10-16
- Stanford professor: AI-done homework scores high, students fail in-person finals — FinanceYF5 · 2026-10-16
- Data brokers pay $100K–$2M for SaaS datasets that may train their own replacements — FinanceYF5 · 2026-10-16
- tszzl: Pretraining science is like steam engines before thermodynamics, slouching toward interpretability — tszzl · 2026-10-16